Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Sep 1, 2016
Insider Transaction Report
Form 4
Maniar Manoj
SVP - Product Development
Transactions
- Award
Stock Option (right to buy)
2016-09-01+17,000→ 17,000 totalExercise: $3.24Exp: 2026-09-01→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]These options vest over three years in 36 equal monthly installments.